Published in Spat Vis on January 01, 1997
Clinical treatment options for patients with homonymous visual field defects. Clin Ophthalmol (2008) 0.93
A matter of time: improvement of visual temporal processing during training-induced restoration of light detection performance. Front Psychol (2015) 0.79
What does Neural Plasticity Tell us about Role of Primary Visual Cortex (V1) in Visual Awareness? Front Psychol (2011) 0.78
What lies beneath: a comparison of reading aloud in pure alexia and semantic dementia. Cogn Neuropsychol (2014) 0.78
A computerized perimeter for assessing modality-specific visual field loss. Conf Proc IEEE Eng Med Biol Soc (2011) 0.77
Visual rehabilitation: visual scanning, multisensory stimulation and vision restoration trainings. Front Behav Neurosci (2015) 0.77
Rehabilitation of damage to the visual brain. Rev Neurol (Paris) (2012) 0.75
Computer-based training for the treatment of partial blindness. Nat Med (1998) 2.80
Raster-scan cathode-ray tubes for vision research--limits of resolution in space, time and intensity, and some solutions. Spat Vis (1997) 2.48
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Fitting the psychometric function. Percept Psychophys (1999) 1.92
Does visual restitution training change absolute homonymous visual field defects? A fundus controlled study. Br J Ophthalmol (2005) 1.54
Caldendrin, a novel neuronal calcium-binding protein confined to the somato-dendritic compartment. J Biol Chem (1998) 1.31
Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci (1998) 1.27
Stability of visual field enlargements following computer-based restitution training -- results of a follow-up. J Clin Exp Neuropsychol (2001) 1.19
Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci (1996) 1.15
Restoration of vision II: residual functions and training-induced visual field enlargement in brain-damaged patients. Restor Neurol Neurosci (1999) 1.11
Residual vision in transition zones in patients with cerebral blindness. J Clin Exp Neuropsychol (1998) 1.10
Assessing spatial vision - automated measurement of the contrast-sensitivity function in the hooded rat. J Neurosci Methods (2000) 1.10
Visual field enlargement after computer training in brain-damaged patients with homonymous deficits: an open pilot trial. Restor Neurol Neurosci (1995) 1.08
Apoptotic versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury. J Neurotrauma (1999) 1.06
Vision restoration therapy. Br J Ophthalmol (2005) 1.04
Unusual spontaneous and training induced visual field recovery in a patient with a gunshot lesion. J Neurol Neurosurg Psychiatry (2001) 0.97
Acute effects of alcohol on divided and covert attention in men. Psychopharmacology (Berl) (2001) 0.97
GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve. Brain Res (1991) 0.94
Toward a unified theory of ganglioside-mediated functional restoration after brain injury: lesion size, not lesion site, is the primary factor determining efficacy. Acta Neurobiol Exp (Wars) (1990) 0.90
Computer-based training of stimulus detection improves color and simple pattern recognition in the defective field of hemianopic subjects. J Cogn Neurosci (2000) 0.90
Automobile driving performance of brain-injured patients with visual field defects. Am J Phys Med Rehabil (1999) 0.90
Reaction time in automated kinetic perimetry: effects of stimulus luminance, eccentricity, and movement direction. Vision Res (2001) 0.89
[The neuroophthalmic supplement to the NEI-VFQ: test statistics and validation with a cohort of patients with pre- and postchiasmatic damage]. Klin Monbl Augenheilkd (2011) 0.88
Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res (1996) 0.88
Altered white matter integrity in adolescents with prelingual deafness: a high-resolution tract-based spatial statistics imaging study. AJNR Am J Neuroradiol (2012) 0.87
Recovery of brightness discrimination in adult rats despite progressive loss of retrogradely labelled retinal ganglion cells after controlled optic nerve crush. Eur J Neurosci (1993) 0.85
Visual hallucinations during spontaneous and training-induced visual field recovery. Neuropsychologia (2007) 0.84
Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides (1998) 0.84
Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease. Exp Neurol (2000) 0.83
Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restor Neurol Neurosci (1990) 0.83
Amplitude and phase characteristics of the steady-state visual evoked potential. Appl Opt (1988) 0.83
Two faces of calcium activation after optic nerve trauma: life or death of retinal ganglion cells in vivo depends on calcium dynamics. Eur J Neurosci (2007) 0.83
Anatomical correlations of intrinsic axon repair after partial optic nerve crush in rats. Ann Anat (2002) 0.83
Controlled release of dopamine from a polymeric brain implant: in vitro characterization. Exp Neurol (1989) 0.82
Expression and subcellular localization of p42IP4/centaurin-alpha, a brain-specific, high-affinity receptor for inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate in rat brain. Eur J Neurosci (1997) 0.82
[Impairments of vision- and health-related quality of life in stroke patients with homonymous visual field defects depend on severity of visual function loss]. Klin Monbl Augenheilkd (2009) 0.81
Structural abnormalities in early Tourette syndrome children: a combined voxel-based morphometry and tract-based spatial statistics study. PLoS One (2013) 0.81
In vivo imaging of mammalian central nervous system neurons with the in vivo confocal neuroimaging (ICON) method. Methods Enzymol (1999) 0.81
An explicit no response instead of time-out in automated visual-field testing. Graefes Arch Clin Exp Ophthalmol (2001) 0.81
Auditory temporal-order judgement is impaired in patients with cortical lesions in posterior regions of the left hemisphere. Neurosci Lett (1999) 0.80
[Visual field defects after cerebral lesions from the patient's perspective: health- and vision-related quality of life assessed by SF-36 and NEI-VFQ]. Nervenarzt (2008) 0.80
Quantification of the human lateral geniculate nucleus in vivo using MR imaging based on morphometry: volume loss with age. AJNR Am J Neuroradiol (2012) 0.80
Restoration of vision IV: role of compensatory soma swelling of surviving retinal ganglion cells in recovery of vision after optic nerve crush. Restor Neurol Neurosci (2001) 0.79
A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers. Neurosci Lett (1994) 0.79
GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage. Science (1984) 0.79
Amphetamine induces hypermotility in MPTP-lesioned mice. Pharmacol Biochem Behav (1997) 0.79
Susceptibility of retinal ganglion cells to excitotoxicity depends on soma size and retinal eccentricity. Curr Eye Res (1999) 0.79
Restoration of vision after optic nerve lesions with noninvasive transorbital alternating current stimulation: a clinical observational study. Brain Stimul (2011) 0.78
L-type calcium channel antagonist nifedipine reduces neurofilament restitution following traumatic optic nerve injury. Acta Neurochir Suppl (2004) 0.78
Co-expression of c-Jun and ATF-2 characterizes the surviving retinal ganglion cells which maintain axonal connections after partial optic nerve injury. Brain Res Mol Brain Res (1999) 0.78
MK-801 reduces retinal ganglion cell survival but improves visual performance after controlled optic nerve crush. J Neurotrauma (1996) 0.78
Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice. Life Sci (2000) 0.78
Influence of nanoparticles on the brain-to-serum distribution and the metabolism of valproic acid in mice. J Pharm Pharmacol (2000) 0.78
Intracerebral injections of isotonic saline prevent behavioral deficits from brain damage. Physiol Behav (1982) 0.78
Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes. Exp Neurol (1992) 0.78
Protease-activated receptor subtype expression in developing eye and adult retina of the rat after optic nerve crush. J Neurosci Res (2003) 0.78
Extensive loss of subcortical neurons in the aging rat brain. Exp Neurol (1981) 0.78
Behavioral effects of intracerebral injections of renin and captopril in intact and brain-damaged rats. Brain Res Bull (1983) 0.78
[Do patients undergo changes of their personality due to visual field defects? An investigation with FPI-R and NEI-VQ]. Klin Monbl Augenheilkd (2008) 0.78
Charles Bonnet syndrome (visual hallucinations) following enucleation. Eye (Lond) (2006) 0.77
Pharmacological treatment of central nervous system injury. Nature (1986) 0.77
Editorial: Residual vision and plasticity after visual system damage. Restor Neurol Neurosci (1999) 0.77
Changes in rapidly transported proteins associated with development of abnormal projections in the diencephalon. Brain Res (1992) 0.77
Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory. Br J Pharmacol (2000) 0.77
Restoration of vision III: soma swelling dynamics predicts neuronal death or survival after optic nerve crush in vivo. Neuroreport (1999) 0.77
Steady-state pattern VEP uncorrelated with suprathreshold contrast perception. Hum Neurobiol (1986) 0.77
Reduction of anterograde degeneration in brain damaged rats by GM1-gangliosides. Neurosci Lett (1987) 0.76
Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants. Behav Brain Res (1998) 0.76
Axonal injury alters alternative splicing of the retinal NR1 receptor: the preferential expression of the NR1b isoforms is crucial for retinal ganglion cell survival. J Neurosci (1998) 0.76
[Sighted and blind in one person: a case report and conclusions on the psychoneurobiology of vision]. Nervenarzt (2007) 0.76
Long-term stability of PBCA nanoparticle suspensions. J Microencapsul (2000) 0.76
Small drug sample fabrication of controlled release polymers using the microextrusion method. J Neurosci Methods (1998) 0.76
Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats. Invest Ophthalmol Vis Sci (1996) 0.75
Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding. J Pharmacol Exp Ther (1994) 0.75
Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats. Eur Neuropsychopharmacol (1999) 0.75
[Chronic visual hallucinations and illusions following brain lesions. A single case study]. Fortschr Neurol Psychiatr (1998) 0.75
Gangliosides minimize behavioral deficits and enhance structural repair after brain injury. J Neurosci Res (1984) 0.75
Special issues in brain plasticity, repair and rehabilitation: 20 years of a publishing strategy. Restor Neurol Neurosci (2010) 0.75
Opto-electronic belts for recording respiration in psychophysiological experimentation and therapy. Psychophysiology (1983) 0.75
Publishing in the field of brain plasticity, repair and rehabilitation: The 20th Anniversary issue of Restorative Neurology and Neuroscience. Restor Neurol Neurosci (2009) 0.75
[Methodological principles for optimising functional MR experiments]. Radiologe (2005) 0.75
Deficits of respiratory-cardiac coupling in heavy drinkers. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.75
Generalizing the evaluation of medical image processing tools by use of Gabor patterns. Methods Inf Med (2009) 0.75
[Possibilities for mobility of blind patients]. Klin Monbl Augenheilkd (1999) 0.75
Diffusion enhancement of drugs by loaded nanoparticles in vitro. Prog Neuropsychopharmacol Biol Psychiatry (1999) 0.75
Molecular plasticity of retinal ganglion cells after partial optic nerve injury. Restor Neurol Neurosci (1999) 0.75
[Transcendental meditation in psychology, psychiatry and psychotherapy]. Med Klin (1979) 0.75
Recovery of metabolic activity in retinofugal targets after traumatic optic nerve injury is independent of retinofugal input. Restor Neurol Neurosci (1998) 0.75
Loss and subsequent recovery of local cerebral glucose use in visual targets after controlled optic nerve crush in adult rats. Exp Neurol (1996) 0.75
The saline effect: minimizing the severity of brain damage by reduction of secondary degeneration. Exp Neurol (1985) 0.75
The role of striatal glutamatergic system in haloperidol-induced dopamine receptor supersensitivity and effects of monosialoganglioside GM1. Pharmacol Biochem Behav (1997) 0.75
GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitransections of the nigro-striatal pathway. Exp Brain Res (1985) 0.75
R-esp1, a rat homologue of drosophila groucho, is differentially expressed after optic nerve crush and mediates NGF-induced survival of PC12 cells. FEBS Lett (1999) 0.75
Science reunification in Germany: a crash program. Science (1993) 0.75
Evidence for gene transcription of adenohypophyseal hormones in the ovine pars tuberalis. Neuroendocrinology (1996) 0.75
Isolation of functionally intact pig retina mitochondria. Acta Ophthalmol Scand (1996) 0.75